LUNGPulmonx Corporation

$75M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+25.0% YoY

Gross Profit

$14M74.2% margin

Operating Income

-$14M-72.2% margin

Net Income

-$14M-72.0% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+9.1%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$178M

Total Liabilities

$59M

Stockholders' Equity

$118M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$15M	+25.0%
Gross Profit	$14M	$11M	+27.9%
Operating Income	-$14M	-$15M	+4.8%
Net Income	-$14M	-$14M	+2.8%

Geographic Segments

UNITED STATES

$14M71%

EMEA

$5M24%

Asia Pacific

$821,0004%

Other International Geographical Areas

$96,0000%

LUNG Q4 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena